1. Ahmed , R., L. A. Morrison , D. M. Knipe 1997 Viral persistence 181 205 In N. Nathanson , R. Bosenge , F. Gonzalez-Scarano , D. E. Griffin , K. V. Winkelman , F. A. Murphy H. L. Robinson Viral Pathogenesis Lippincott-Raven Publishers, Philadelphia, Pa
2. Improving rAAV production and purification: towards the definition of a scalable process;Blouin;J. Gene Med.,2004
3. Transfection-free and scalable recombinant AAV vector production using HSV/AAV hybrids;Booth;Gene Ther.,2004
4. Virus-based vectors for gene expression in mammalian cells: adeno-virus;Bourbeau;Gene Transfer and Expression in Mammalian Cells,2003
5. Braun , A. 1999 Biosafety in handling gene therapy vectors, p. 12.0.1-12.7.11 In N. C. Dracopoli , J. L. Haines , B. R. Korf , C. C. Winkelman , C. E. Seidman , J. G. Seidman D. R. Smith Current Protocols in Human Genetics Wiley, New York, N.Y